Development of IVD assays and workflows for rapid sample to result nucleic acid based point of care diagnostics and patient stratification, primarily intended for resource limited settings (eg. HCV, TB, HIV, HBV).Molecular modalities for target discovery and biomarker discovery and clinical application - pharma & biotech services

Head of "Omics" Technologies (Genomics and Proteomics) for the Translational Medicine Research Collaboration, Wyeth Research. Biomarker and target identification and validation, across multiple therapeutic areas.

Head of Genomics for the Translational Medicine Research Collaboration, Wyeth Research. Biomarker and target identification and validation, across multiple therapeutic areas.

Honorary lecturer at the University of Dundee Biomedical Research Institute

Research fellow, functional genomics of prion diseases, molecular mechanisms underpinning prion pathogenesis & discovery of disease biomarkers. Group of Prof. Adriano Aguzzi.

BBSRC-funded David Phillips Research fellow. Five year independent programme, first two years of which spent in the laboratory of Prof. Adriano Aguzzi in the University Hospital Zurich, researching the molecular mechanisms underpinning prion disease pathogenesis.

Postdoctoral fellow using gene expression profiling technology to investigate the molecular mechanisms underpinning prion disease pathogenesis, and discovery of disease biomarkers.

Research scientist utilising gene expression profiling technology to investigate the normal physiological function of the cellular prion protein.

Research assistant studying the RNA packaging signal structure of HIV type 1.